• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.糖化白蛋白是2型糖尿病非危重症住院患者炎症的新型标志物。
Inflammation. 2015;38(3):1357-63. doi: 10.1007/s10753-014-0107-8.
2
A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome.一种促炎糖蛋白生物标志物与代谢综合征中较低的胆红素相关。
Clin Biochem. 2015 Nov;48(16-17):1045-7. doi: 10.1016/j.clinbiochem.2015.06.016. Epub 2015 Jun 27.
3
GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status.炎症性糖蛋白的生物标志物糖化白蛋白(GlycA)与瘦素/脂联素比值的关系比与葡萄糖耐量状态的关系更为密切。
Clin Biochem. 2015 Aug;48(12):811-4. doi: 10.1016/j.clinbiochem.2015.05.001. Epub 2015 May 11.
4
A novel protein glycan biomarker and LCAT activity in metabolic syndrome.代谢综合征中的一种新型蛋白质聚糖生物标志物及卵磷脂胆固醇酰基转移酶活性
Eur J Clin Invest. 2015 Aug;45(8):850-9. doi: 10.1111/eci.12481.
5
GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.急性期糖蛋白标志物糖化白蛋白(GlycA)与2型糖尿病发病风险:荷兰预防和早期糖尿病肾病研究(PREVEND研究)
Clin Chim Acta. 2016 Jan 15;452:10-7. doi: 10.1016/j.cca.2015.11.001. Epub 2015 Nov 5.
6
GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.促炎糖蛋白生物标志物GlycA与心血管疾病的发生:与C反应蛋白及肾功能的关系
PLoS One. 2015 Sep 23;10(9):e0139057. doi: 10.1371/journal.pone.0139057. eCollection 2015.
7
GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.GlycA是一种新型炎症标志物,在系统性红斑狼疮中升高。
Lupus. 2016 Mar;25(3):296-300. doi: 10.1177/0961203315617842. Epub 2015 Dec 3.
8
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.一种新型炎症生物标志物GlycA与类风湿关节炎的疾病活动以及体重指数匹配的对照人群的心血管代谢风险相关。
Arthritis Res Ther. 2016 Apr 12;18:86. doi: 10.1186/s13075-016-0982-5.
9
Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects.较高的循环糖基化终末产物(GlycA),一种促炎糖蛋白生物标志物,在非糖尿病受试者中与脂蛋白相关磷脂酶A2质量相关,但在糖尿病或代谢综合征受试者中则不然。
J Clin Lipidol. 2016 May-Jun;10(3):512-8. doi: 10.1016/j.jacl.2015.11.009. Epub 2015 Nov 22.
10
GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.糖化白蛋白和高敏 C 反应蛋白是接受血管造影术的患者未来心血管事件的独立且可相加的预测因子:山间心脏协作研究。
Am Heart J. 2018 Aug;202:27-32. doi: 10.1016/j.ahj.2018.04.003. Epub 2018 Apr 6.

引用本文的文献

1
Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review.解读2型糖尿病危险因素的复杂相互作用:一项综述
Metabol Open. 2024 May 19;22:100287. doi: 10.1016/j.metop.2024.100287. eCollection 2024 Jun.
2
Glycoprotein Acetyls Associate With Intraglomerular Hemodynamic Dysfunction, Albuminuria, Central Adiposity, and Insulin Resistance in Youth With Type 1 Diabetes.糖化蛋白乙酰化与青少年 1 型糖尿病患者肾小球内血流动力学功能障碍、蛋白尿、中心性肥胖和胰岛素抵抗相关。
Can J Diabetes. 2024 Jun;48(4):244-249.e1. doi: 10.1016/j.jcjd.2024.01.010. Epub 2024 Feb 8.
3
Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates.糖基化终产物A(GlycA)和糖基化终产物B(GlycB)在早期检测与(预)糖尿病及心血管疾病相关炎症中的临床应用:最新证据与进展
J Inflamm (Lond). 2023 Oct 9;20(1):32. doi: 10.1186/s12950-023-00358-7.
4
Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical Parameters.定量血清核磁共振波谱法对新冠肺炎患者进行分层,并揭示宿主代谢以及免疫反应与细胞因子和临床参数之间的关联。
Metabolites. 2022 Dec 16;12(12):1277. doi: 10.3390/metabo12121277.
5
Metabolomic serum abnormalities in dogs with hepatopathies.犬肝胆疾病的代谢组学血清异常。
Sci Rep. 2022 Mar 29;12(1):5329. doi: 10.1038/s41598-022-09056-5.
6
Glycoprotein Profile Measured by a H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation.基于氢核磁共振方法测量糖尿病患者的糖蛋白谱:一种评估炎症的新的可靠方法。
Life (Basel). 2021 Dec 16;11(12):1407. doi: 10.3390/life11121407.
7
GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.糖化白蛋白:一种用于全身炎症和心血管疾病(CVD)风险评估的新型生物标志物。
J Lab Precis Med. 2020 Apr;5. doi: 10.21037/jlpm.2020.03.03. Epub 2020 Apr 20.
8
The Exercise Training Modulatory Effects on the Obesity-Induced Immunometabolic Dysfunctions.运动训练对肥胖诱导的免疫代谢功能障碍的调节作用。
Diabetes Metab Syndr Obes. 2020 Mar 19;13:785-810. doi: 10.2147/DMSO.S234992. eCollection 2020.
9
Title: Human Serum/Plasma Glycoprotein Analysis by H-NMR, an Emerging Method of Inflammatory Assessment.标题:通过氢核磁共振波谱分析人血清/血浆糖蛋白,一种新兴的炎症评估方法。
J Clin Med. 2020 Jan 27;9(2):354. doi: 10.3390/jcm9020354.
10
Increased glycoprotein acetylation is associated with high cardiac event rates: Analysis using coronary computed tomography angiography.糖蛋白乙酰化增加与高心脏事件发生率相关:使用冠状动脉计算机断层扫描血管造影的分析。
Anatol J Cardiol. 2018 Sep;20(3):152-158. doi: 10.14744/AnatolJCardiol.2018.01058.

本文引用的文献

1
A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation.2型糖尿病合并充血性心力衰竭加重患者持续静脉注射胰岛素与皮下注射胰岛素的比较。
Diabetes Metab Res Rev. 2015 Jan;31(1):93-101. doi: 10.1002/dmrr.2569.
2
Prandial insulin dosing using the carbohydrate counting technique in hospitalized patients with type 2 diabetes.在住院的2型糖尿病患者中使用碳水化合物计数技术进行餐时胰岛素给药。
Diabetes Care. 2013 Nov;36(11):3476-82. doi: 10.2337/dc13-0121. Epub 2013 Sep 23.
3
Insulin resistance and inflammation markers in myocardial infarction.心肌梗死患者的胰岛素抵抗与炎症标志物。
J Inflamm Res. 2013 Jun 17;6:83-90. doi: 10.2147/JIR.S43081. Print 2013.
4
Insulin resistance in patients with chronic kidney disease.慢性肾病患者的胰岛素抵抗
J Biomed Biotechnol. 2012;2012:691369. doi: 10.1155/2012/691369. Epub 2012 Aug 7.
5
Comparison of inflammatory markers between diabetic and nondiabetic ST segment elevation myocardial infarction.比较糖尿病和非糖尿病 ST 段抬高型心肌梗死患者的炎症标志物。
J Cardiol. 2012 Sep;60(3):204-9. doi: 10.1016/j.jjcc.2012.03.006. Epub 2012 May 31.
6
Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis.新诊断 1 型糖尿病伴酮症酸中毒患儿血浆高敏 C 反应蛋白及其与细胞因子水平的关系。
Clin Biochem. 2012 Nov;45(16-17):1383-8. doi: 10.1016/j.clinbiochem.2012.05.003. Epub 2012 May 11.
7
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.非重症监护环境住院患者高血糖管理:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2012 Jan;97(1):16-38. doi: 10.1210/jc.2011-2098.
8
Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: a randomized controlled trial.静脉注射胰岛素对 2 型糖尿病经皮冠状动脉介入治疗支架后炎症和氧化应激标志物的影响:一项随机对照试验。
J Clin Endocrinol Metab. 2011 Feb;96(2):478-85. doi: 10.1210/jc.2010-0256. Epub 2010 Nov 17.
9
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.1型或2型糖尿病患者血糖控制与糖尿病相关住院费用之间的关系。
J Manag Care Pharm. 2010 May;16(4):264-75. doi: 10.18553/jmcp.2010.16.4.264.
10
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.危重症患者中与高血糖相关的死亡率因入院诊断而异。
Crit Care Med. 2009 Dec;37(12):3001-9. doi: 10.1097/CCM.0b013e3181b083f7.

糖化白蛋白是2型糖尿病非危重症住院患者炎症的新型标志物。

GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.

作者信息

Dungan Kathleen, Binkley Philip, Osei Kwame

机构信息

Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, 5th Floor McCampbell Hall, 1581 Dodd Drive, Columbus, OH, 43210-1296, USA,

出版信息

Inflammation. 2015;38(3):1357-63. doi: 10.1007/s10753-014-0107-8.

DOI:10.1007/s10753-014-0107-8
PMID:25586483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4425594/
Abstract

GlycA is a nuclear magnetic resonance-derived signal that originates from oligosaccharide chains of acute phase proteins. The objective of this study is to characterize GlycA levels in hospitalized non-critically ill patients with type 2 diabetes. This study evaluated traditional and novel (GlycA) inflammatory markers among 121 patients who were stratified by admission diagnoses: congestive heart failure (CHF), cardiac non-CHF (CARD), infection (INF), and other (OTH). HbA1c was similar across groups (8.0-9.2%, p=0.20). Inflammatory markers were elevated but varied significantly across disease categories, with the highest values of interleukin-6 (IL-6), c-reactive protein (CRP), and GlycA in the INF group and the highest tumor necrosis factor-α and intracellular adhesion molecule-1 levels in CHF group. GlycA was associated with higher IL-6 and CRP, lower hemoglobin, and lower glomerular filtration rate. GlycA and other inflammatory markers were not significantly associated with admission glucose or HbA1c. Among hospitalized non-critically ill patients with type 2 diabetes, GlycA was highest in INF patients and was associated with IL-6 and CRP. None of the markers were significant predictors of glucose control.

摘要

糖化白蛋白(GlycA)是一种源自急性期蛋白寡糖链的核磁共振衍生信号。本研究的目的是对住院的非危重型2型糖尿病患者的GlycA水平进行特征描述。本研究评估了121例患者的传统和新型(GlycA)炎症标志物,这些患者按入院诊断分层为:充血性心力衰竭(CHF)、非CHF心脏疾病(CARD)、感染(INF)和其他(OTH)。各组间糖化血红蛋白(HbA1c)相似(8.0 - 9.2%,p = 0.20)。炎症标志物升高,但在不同疾病类别中差异显著,INF组白细胞介素-6(IL-6)、C反应蛋白(CRP)和GlycA值最高,CHF组肿瘤坏死因子-α和细胞间黏附分子-1水平最高。GlycA与较高的IL-6和CRP、较低的血红蛋白以及较低的肾小球滤过率相关。GlycA和其他炎症标志物与入院时血糖或HbA1c无显著关联。在住院的非危重型2型糖尿病患者中,INF患者的GlycA最高,且与IL-6和CRP相关。这些标志物均不是血糖控制的显著预测指标。